Country: Bretland
Tungumál: enska
Heimild: MHRA (Medicines & Healthcare Products Regulatory Agency)
Candesartan cilexetil
Milpharm Ltd
C09CA06
Candesartan cilexetil
2mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02050502; GTIN: 8901175018529
CANDESARTAN CILEXETIL 2 MG TABLETS CANDESARTAN CILEXETIL 4 MG TABLETS CANDESARTAN CILEXETIL 8 MG TABLETS CANDESARTAN CILEXETIL 16 MG TABLETS CANDESARTAN CILEXETIL 32 MG TABLETS candesartan cilexetil PACKAGE LEAFLET: INFORMATION FOR THE USER READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Candesartan cilexetil is and what it is used for 2. What you need to know before you take Candesartan cilexetil 3. How to take Candesartan cilexetil 4. Possible side effects 5. How to store Candesartan cilexetil 6. Contents of the pack and other information The name of your medicine is Candesartan cilexetil. The active ingredient is candesartan cilexetil. This belongs to a group of medicines called angiotensin II receptor antagonists. It works by making your blood vessels relax and widen. This helps to lower your blood pressure. It also makes it easier for your heart to pump blood to all parts of your body. This medicine is used for: • treating high blood pressure (hypertension) in adult patients and in children and adolescents aged 6 to <18 years. • Candesartan cilexetil can be used to treat adult heart failure patients with reduced heart muscle function when Angiotensin Converting Enzyme (ACE) inhibitors cannot be used or in addition to ACE-inhibitors when symptoms persist despite treatment and mineralocorticoid receptor antagonists (MRA) cannot be used. (ACE-inhibitors and MRAs are medicines used to treat heart failure). DO NOT TAKE CANDESARTAN CILEXETIL: • if you are allergic to candesartan cilexetil o Lestu allt skjalið
OBJECT 1 CANDESARTAN CILEXETIL 2MG TABLETS Summary of Product Characteristics Updated 06-Apr-2017 | Aurobindo Pharma - Milpharm Ltd. 1. Name of the medicinal product Candesartan Cilexetil 2 mg tablets 2. Qualitative and quantitative composition Each tablet contains 2 mg candesartan cilexetil. Excipient with known effect: Lactose monohydrate. Each tablet contains 140 mg lactose monohydrate. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Tablet White to off-white, biconvex, uncoated, round shaped [diameter 7.3 mm] tablets debossed with "J10" on one side and plain on other side. 4. Clinical particulars 4.1 Therapeutic indications Candesartan Cilexetil is indicated for the: • Treatment of essential hypertension in adults. • Treatment of hypertension in children and adolescents aged 6 to <18 years. • The treatment of adult patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction ≤ 40%) when ACE-inhibitors are not tolerated or as add-on therapy to ACE- inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated (see Sections 4.2, 4.4, 4.5 and 5.1). 4.2 Posology and method of administration Posology in Hypertension The recommended initial dose and usual maintenance dose of Candesartan Cilexetil is 8 mg once daily. Most of the antihypertensive effect is attained within 4 weeks. In some patients whose blood pressure is not adequately controlled, the dose can be increased to 16 mg once daily and to a maximum of 32 mg once daily. Therapy should be adjusted according to blood pressure response. Candesartan Cilexetil may also be administered with other antihypertensive agents. Addition of hydrochlorothiazide has been shown to have an additive antihypertensive effect with various doses of Candesartan Cilexetil. _Elderly population_ No initial dose adjustment is necessary in elderly patients. _Patients with intravascular volume depletion_ An initial dose of 4 Lestu allt skjalið